The effects of nelumal A on proliferation and apoptosis might contribute to decreasing the incidence and multiplicity of adenocarcinoma by reducing the inflammation and oxidative stress in the colon mucosa as described above as well as through the direct anticancer action of the FXR agonist, which has also been previously reported36. The gene discussed is NR1H4; the disease is adenocarcinoma.